Status:
TERMINATED
Genetic Analysis of Liver Cancer
Lead Sponsor:
Samuel So
Conditions:
Liver Cancer
Hepatitis B
Eligibility:
MALE
18+ years
Brief Summary
Liver cancer is a leading cause of cancer deaths worldwide. While the molecular pathogenesis of liver cancer has been extensively studied, less is known about how the molecular biology of liver cancer...
Eligibility Criteria
Inclusion
- 1.1 Male or female patients 18 years of age and above. 3.1.2 Patients diagnosed with liver cancer based on biopsy or serum alpha-fetoprotein level, associated with characteristic hypervascular liver tumors on triphasic spiral CT scan or MRI. Patients with non-cancer liver conditions such as cirrhosis, adenoma, cholangioma, or nodular hyperplasia. Patients with metastatic tumor from anther organ, such as metastatic colon cancer.
- 13 Ability to understand and the willingness to sign a written informed consent document.
Exclusion
- 2.1Female patients who are pregnant or nursing will be excluded from the study.
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT00768001
Start Date
June 1 2008
End Date
October 1 2011
Last Update
February 1 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305